Search results
Two local RNA-focused biotechs merge, plan to go public 'at some point' - Boston Business Journal
The Business Journals· 35 minutes agoMunshi has experience running larger public companies, having previously led Arena Pharmaceuticals Inc. before its acquisition for $6.7 billion by Pfizer. Munshi said the ...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 4 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks· 1 day agoFree Report) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 200-day moving average, and this suggests a long-term bullish trend. The ...
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units
RTT News· 1 day agoHospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection ...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 7 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Pfizer targets $1.5 billion in savings by 2027 as it streamlines operations
WHTC 1450 Holland· 2 days ago(Reuters) -U.S. drugmaker Pfizer said on Wednesday it had launched a multi-year program to reduce...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 19 hours agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 2 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 7 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...